Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP557490.RAeTC1d6C-PU1UMNIqF_WMdL_5LE9F-T_ybq4g5t_cIOk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP557490.RAeTC1d6C-PU1UMNIqF_WMdL_5LE9F-T_ybq4g5t_cIOk130_assertion type Assertion NP557490.RAeTC1d6C-PU1UMNIqF_WMdL_5LE9F-T_ybq4g5t_cIOk130_head.
- NP557490.RAeTC1d6C-PU1UMNIqF_WMdL_5LE9F-T_ybq4g5t_cIOk130_assertion wasGeneratedBy ECO_0000203 NP557490.RAeTC1d6C-PU1UMNIqF_WMdL_5LE9F-T_ybq4g5t_cIOk130_provenance.
- NP557490.RAeTC1d6C-PU1UMNIqF_WMdL_5LE9F-T_ybq4g5t_cIOk130_assertion wasDerivedFrom befree-2016 NP557490.RAeTC1d6C-PU1UMNIqF_WMdL_5LE9F-T_ybq4g5t_cIOk130_provenance.
- NP557490.RAeTC1d6C-PU1UMNIqF_WMdL_5LE9F-T_ybq4g5t_cIOk130_assertion SIO_000772 16812949 NP557490.RAeTC1d6C-PU1UMNIqF_WMdL_5LE9F-T_ybq4g5t_cIOk130_provenance.
- NP557490.RAeTC1d6C-PU1UMNIqF_WMdL_5LE9F-T_ybq4g5t_cIOk130_assertion evidence source_evidence_literature NP557490.RAeTC1d6C-PU1UMNIqF_WMdL_5LE9F-T_ybq4g5t_cIOk130_provenance.
- NP557490.RAeTC1d6C-PU1UMNIqF_WMdL_5LE9F-T_ybq4g5t_cIOk130_assertion description "[We evaluated whether cytochrome P450 (CYP) poor metabolizer polymorphisms of CYP2D6 and CYP2C19 are relevant for the outcome (measured by length of hospitalization) during treatment with psychotropic medications in patients with depression or schizophrenia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557490.RAeTC1d6C-PU1UMNIqF_WMdL_5LE9F-T_ybq4g5t_cIOk130_provenance.